
Newcastle-based biotech firm Glythera has appointed Dr Nigel Burns as non-executive director and Ian Evetts as commercial director. Burns (pictured) …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

